Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Vitamin C  COVID-19 treatment studies for Vitamin C  C19 studies: Vitamin C  Vitamin C   Select treatmentSelect treatmentTreatmentsTreatments
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta
Lactoferrin Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Hospitalization 31% Improvement Relative Risk c19early.org/c Guldemir et al. Vitamin C for COVID-19 Prophylaxis Favors vitamin C Favors control
Clinical characteristics of bus drivers and field officers infected with COVID-19: A cross-sectional study from Istanbul
Guldemir et al., Work, doi:10.3233/wor-220292
Guldemir et al., Clinical characteristics of bus drivers and field officers infected with COVID-19: A cross-sectional study.., Work, doi:10.3233/wor-220292
Nov 2022   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Retrospective 477 COVID+ public transportation workers in Turkey, showing lower risk of hospitalization with vitamin C use in unadjusted results. This study is excluded in the after exclusion results of meta analysis: unadjusted results with no group details.
risk of hospitalization, 31.0% lower, RR 0.69, p = 0.046 (Fisher's exact test), treatment 33 of 173 (19.1%), control 84 of 304 (27.6%), NNT 12.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Guldemir et al., 16 Nov 2022, retrospective, Turkey, peer-reviewed, 3 authors, study period 30 March, 2020 - 23 September, 2020.
Contact: hilalhizliguldemir@anadolu.edu.tr.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperVitamin CAll
Abstract: 1 Work xx (2022) x–xx DOI:10.3233/WOR-220292 IOS Press 2 3 Clinical characteristics of bus drivers and field officers infected with COVID-19: A cross-sectional study from Istanbul roo f 1 Hilal Hizli Guldemira∗ , Merve Kayali Sevimb and Serkan Etic 5 a Department of Nutrition and Dietetics, Faculty of Health Sciences, Anadolu University, Eskisehir, Turkey 6 b Institute of Health Sciences, Istanbul Medipol University, Istanbul, Turkey Au tho rP 4 c Department of Computer Programming, Istanbul Medipol University, Istanbul, Turkey 7 9 8 Received 4 June 2022 Accepted 6 October 2022 26 Keywords: Body mass index, occupational groups, obesity, pandemic 27
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit